Multi-site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM)
Existing collection in use without an OMB Control Number
Yes
Regular
Approved with change
07/15/2021
07/07/2021
CDC will characterize all limitations of this study in any publications or citations where this data is used.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
07/31/2024
36 Months From Approved
3,525
0
0
715
0
0
0
0
0
This study uses a standardized approach for data collection to examine the heterogeneity of patients with ME/CFS using a clinical epidemiologic longitudinal study with a retrospective and prospective rolling cohort design. The study also aims to address the issue of ME/CFS case definition and improve measures of illness domains by using evidence-based data from multiple clinical practices in the United States. Healthy adults and those with illnesses that share some features with ME/CFS were enrolled in comparison groups. Child and adolescent ME/CFS and healthy participants were also enrolled.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.